Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (12) , 1960-1975
- https://doi.org/10.1016/j.clinthera.2004.12.019
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Predictors of joint damage in rheumatoid arthritisAPMIS, 1996
- Dysregulation of the in vivo production of interleukin‐1 receptor antagonist in patients with rheumatoid arthritis pathogenetic implicationsArthritis & Rheumatism, 1995
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- The Underestimated Long Term Medical and Economic Consequences of Rheumatoid ArthritisDrugs, 1995
- The effect of an interleukin‐1 receptor antagonist protein on type ii collagen–induced arthritis and antigen‐induced arthritis in miceArthritis & Rheumatism, 1993
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- LOCALIZATION OF INTERLEUKIN-1α, TYPE 1 INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE SYNOVIAL MEMBRANE AND CARTILAGE/PANNUS JUNCTION IN RHEUMATOID ARTHRITISRheumatology, 1992
- Biannual Radiographic Assessments of Hands and Feet in a Three‐Year Prospective Followup of Patients with Early Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Biologic effects of an interleukin‐1 receptor antagonist protein on interleukin‐1–stimulated cartilage erosion and chondrocyte responsivenessArthritis & Rheumatism, 1991